Tinnitus Patient Preferences Survey
Launched by NICOLAS GNINENKO · Jan 16, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking for people who experience tinnitus, which is a condition that causes ringing or other noises in the ears, to share their opinions about a potential new treatment. The study will gather information on how patients feel about a brain implant that could help reduce tinnitus symptoms. Researchers want to know if patients would accept the risks of surgery, how easy they think the device would be to use, and whether they would be willing to pay for this treatment if it becomes available.
To participate in this survey, you must be at least 18 years old and have been diagnosed with chronic tinnitus that has lasted for three months or longer. The trial is currently recruiting participants, and anyone who fits this description is encouraged to take part. By sharing your thoughts, you can help shape the development of this new, minimally invasive brain implant aimed at providing relief for those suffering from tinnitus.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Individuals aged 18 or older suffering from subjective tinnitus
- • Self-reported or healthcare professional-diagnosed chronic (lasting 3 months or longer), subjective, burdensome tinnitus
- Exclusion criteria:
- • Individuals under 18 years of age
- • Healthy volunteers without tinnitus
About Nicolas Gninenko
Nicolas Gninenko is an innovative clinical trial sponsor dedicated to advancing medical research and improving patient outcomes. With a strong focus on collaboration and integrity, the organization specializes in designing and managing clinical trials across various therapeutic areas. Leveraging a robust network of healthcare professionals and research institutions, Nicolas Gninenko is committed to delivering high-quality data and fostering the development of safe and effective therapies. Their mission is to accelerate the translation of scientific discoveries into real-world applications, ultimately enhancing the quality of care for patients globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Nicolas Gninenko, PhD
Principal Investigator
Neurosoft Bioelectronics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported